A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets

Author: Ramondetta L.M.   Burke T.W.   Jhingran A.   Schmandt R.   Bevers M.W.   Wolf J.K.   Levenback C.F.   Broaddus R.  

Publisher: Elsevier

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.90, Iss.3, 2003-09, pp. : 529-536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content